Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Antonio Cuadrado; Ana I. Rojo; Geoffrey Wells; John D. Hayes; Sharon P. Cousin; William L. Rumsey; Otis C. Attucks; Stephen Franklin; Anna‐Liisa Levonen; Thomas W. Kensler; Albena T. Dinkova‐Kostova

doi:10.1038/s41573-018-0008-x

Keywords

KEAP1Transcription factorCytoprotectionRegulatorInflammationSignal transducing adaptor proteinMedicineBioinformaticsImmunologyCancer researchBiologyOxidative stressCell biologySignal transductionInternal medicineBiochemistryGene

Affiliated Institutions

Related Publications

An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation

Sarmistha Saha , Brigitta Buttari , Emiliano Panieri +2 more

Inflammation is a key driver in many pathological conditions such as allergy, cancer, Alzheimer’s disease, and many others, and the current state of available drugs prompted res...

2020 Molecules 1178 citations

The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis

Masayuki Yamamoto , Thomas W. Kensler , Hozumi Motohashi

The Kelch-like ECH-associated protein 1-NF-E2-related factor 2 (KEAP1-NRF2) system forms the major node of cellular and organismal defense against oxidative and electrophilic st...

2018 Physiological Reviews 1703 citations

The Molecular Mechanisms Regulating the KEAP1-NRF2 Pathway

Liam Baird , Masayuki Yamamoto

The KEAP1-NRF2 pathway is the principal protective response to oxidative and electrophilic stresses. Under homeostatic conditions, KEAP1 forms part of an E3 ubiquitin ligase, wh...

2020 Molecular and Cellular Biology 1301 citations

Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1

Evanna L. Mills , Dylan G. Ryan , Hiran A. Prag +32 more

The endogenous metabolite itaconate has recently emerged as a regulator of macrophage function, but its precise mechanism of action remains poorly understood. Here we show that ...

2018 Nature 1672 citations

NRF2 and the Hallmarks of Cancer

Montserrat Rojo de la Vega , Eli Chapman , Donna D. Zhang

The transcription factor NRF2 is the master regulator of the cellular antioxidant response. Though recognized originally as a target of chemopreventive compounds that help preve...

2018 Cancer Cell 1516 citations

Publication Info

Year: 2019
Type: review
Volume: 18
Issue: 4
Pages: 295-317
Citations: 1260
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1260

OpenAlex

Cite This

APA Style

                            
                                
                                    Antonio Cuadrado, 
                                
                                    Ana I. Rojo, 
                                
                                    Geoffrey Wells
                                
                                et al.
                            
                            (2019). 
                            Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases. 
                            Nature Reviews Drug Discovery
                            , 18
                            (4)
                            , 295-317.
                            https://doi.org/10.1038/s41573-018-0008-x
                        

Identifiers

DOI: 10.1038/s41573-018-0008-x